Home
Contact Us
About Us
Advertise
Biotech
Finance
Tech News
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
BioPharmaJournal
Home
Contact Us
About Us
Advertise
Biotech
Mustang Bio Inc (NASDAQ: MBIO) Receives Orphan Drug Designation From US…
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment…
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan…
Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes…
Finance
Why Your Body Needs Nitric Oxide Boost Beets For More Energy…
Top Beer Stocks for the Recession-Proof Portfolio (BUD, KEGS, SAM, TAP,…
Cutting Edge Power announces an all-new version of its popular Smart…
Lucid Group Inc (NASDAQ:LCID) Poised for Action as New Catalysts Mount
Galera Therapeutics Inc. (NASDAQ: GRTX) Announced Updated Findings Of Phase 3…
Tech News
Aehr Test Systems (NASDAQ: AEHR) Receives an Order of $10.8 Million…
Tauriga Sciences Inc (OTCMKTS:TAUG) Could React on New Aegea Rapid Test…
Micro and Macro Tailwinds Converge for KULR
ISWH and the Rebirth of the Crypto Cycle
Disclaimer
Home
Tags
NASDAQ:CDMO
Tag: NASDAQ:CDMO
Avid Bioservices Inc (NASDAQ:CDMO) Posts Revenues Of $25.4 Million In Q1...
Kate Hudson
-
September 7, 2020
0
Recent Post
Mustang Bio Inc (NASDAQ: MBIO) Receives Orphan Drug Designation From US...
Kate Hudson
-
July 6, 2022
0
Mustang Bio Inc (NASDAQ: MBIO) has received an Orphan Drug Designation from the US FDA for its CD20-targeted, autologous CAR T cell therapy, MB-106,...
CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...
July 5, 2022
Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA
July 4, 2022
Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...
July 1, 2022
Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...
June 30, 2022
